Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.

doi:10.1002/cpt.2181

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.

Clinical pharmacology and therapeutics - 1 Apr 2021

Pai Manjunath P

Abstract excerpt

Obesity and its related comorbidities can negatively influence the outcomes of certain infectious diseases. Specific dosing recommendations are often lacking in the product label for patients with obesity that leads to unclear guidance in practice. Higher rates of therapeutic failure have been reported with some fixed dose antibiotics and pragmatic approaches to dose modification are limited for orally...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Body Weight
Share to Dose-Response Relationship, Drug
Share to Drug Dosage Calculations
Share to Metabolic Clearance Rate
Share to Obesity
Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 33523485
DOI: 10.1002/cpt.2181
PMCID: PMC8855475

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics